ࡱ > \ p apligina B a = -B0=830 = h X/#8 X@ " 1 " o A r i a l C y r 1 " o A r i a l C y r 1 " o A r i a l C y r 1 " o A r i a l C y r 1 " o A r i a l C y r 1 oG e o r g i a 1 " o A r i a l C y r 1 " o A r i a l C y r 1 " o A r i a l C y r 1 " o A r i a l C y r 1 oA r i a l 1 oG e o r g i a 1 oA r i a l 1 oA r i a l 1 oA r i a l 1 " o A r i a l C y r 1 oA r i a l 1 " o A r i a l C y r 1 " o A r i a l C y r 1 " $ o A r i a l C y r 1
oA r i a l 1
oA r i a l / # , # # 0 " @. " ; \ - # , # # 0 " @. " 9 # , # # 0 " @. " ; [ R e d ] \ - # , # # 0 " @. " ; # , # # 0 . 0 0 " @. " ; \ - # , # # 0 . 0 0 " @. " E # , # # 0 . 0 0 " @. " ; [ R e d ] \ - # , # # 0 . 0 0 " @. " k * 3 _ - * # , # # 0 " @. " _ - ; \ - * # , # # 0 " @. " _ - ; _ - * " - " " @. " _ - ; _ - @ _ - k ) 3 _ - * # , # # 0 _ @_ . _ - ; \ - * # , # # 0 _ @_ . _ - ; _ - * " - " _ @_ . _ - ; _ - @ _ - { , ; _ - * # , # # 0 . 0 0 " @. " _ - ; \ - * # , # # 0 . 0 0 " @. " _ - ; _ - * " - " ? ? " @. " _ - ; _ - @ _ - { + ; _ - * # , # # 0 . 0 0 _ @_ . _ - ; \ - * # , # # 0 . 0 0 _ @_ . _ - ; _ - * " - " ? ? _ @_ . _ - ; _ - @ _ - # , # # 0 . 0 0 " @. " [$$-409]#,##0.00
# # # , 0 \ , 0 0 " @. " [$$-409]###,0\,00 # " 0" ; " 0" ; " 5B" 5 " AB8=0" ; " AB8=0" ; " >6L" ) " :;" ; " :;" ; " K:;" Y * [ $ - 2 ] \ # # # , 0 0 0 _ ) ; [ R e d ] \ ( [ $ - 2 ] \ # # # , 0 0 0 \ ) [$$-409]#,##0.000
# , # # 0 . 0 0 0 " @. " # , # # 0 " @. " 0 . 0 0 " @. " , * + )
, `
" < `
# < `
"
#
|@ @
Z |@ @
|@ @
) 8@ @ # 8@ @ + 8@ @ ) 8@ @ # 8@ @ + 8@ @ ! # " # <@ @ # <@ @ ! 8 ( , ( " ` 0 8AB1 l 8AB2 8m 8AB3 !
= 5 8 = " 5 iY}=Kҭ @= iY}=KҭD x xOTI ǿ
::i% f(" q:LQQ4 1у0M EZ=a?UTˣ1vU]B`# Cday{&ֳ韲{t\Xqs? rݨ/EvkNB'8?)_'țM C[~ҧ \ƶ5(?=GM0P"FD " VàuAիtUgԯpڠY}%`:J,*mڢ֚]uɸL5j.QڭN]jI_=xj/+=HQ8[]0Ut=ګEԓj4;
m%rk:]̻YE}d䮎SRiczHXjd7{K/D,'~Rb(Ǧ U|kqRgccd8ə"ijy2ܨp??ܑL3}-s?2PV`||wJMg_Kx[;V ^ѿcZŸn!6z3᱕o0MFC?r 0!EW1k]L"7 z;p "PDbHSB{{O
cB!PC|#O@z<
c~7z¾}zގ]5 "u Ρ VZ7^Zk:h&N 56䃬`?5 e.O&M;N~Szq A0qCŰ8q
7ac/ tJ:n[҉eʎ^w}/gcO;M3 A @ @
6 !?@8=F>2:0 % - 9 ( A 2 - =5G=, = @5B0@4 B01 1 , 5 D>>= B01; !1 0 0 0;07>;8= D; 0 , 0 5 % 1 0 <; :0?;8 48C< :0?A 2 <3 !6 48C< ?;NA B01 2 ?5@0<84 :0?A 2 <3 !2 0 ( 8=4. C?) 8D0<?8F8= 0<? 5 <; !1 0 !0;L1CB0; 0M@ 1 2 <; !5=045:A8= B01 2 5 0 <3 !1 0 535= N18<K9 -:AB@0 5 0 3@$ 535= 0@>4=K9 9>48@>20==K9 4 0 3# 535= A 28B0;8MB8;5=>2K5 B5:ABC@8@>20==K5 ( ?0@0) 4 "5@<5B@ <548F8=A:89 A 70I8B=K:@KB85< 2 DCB;O@5 5:0@AB25==K5 ?@5?0@0BK
0?0;LG=8: <@ D; 1 0 % 1 0 @18=>20O :- B0 ?>@ 2 , 5 3 5@;8?@8; 5 B01 5 2K9 75;5=K9 D; 1 % 1 0 20O :@KH:0 81@>F8; 35;L 4/ =>A0 1 2 3 BC10 81@>F8; A?@59 4/ =>A0 D; 1 0 ;LB0@5= MB025@8=0 3/ E B01 4 0 2A:0O ?;5=:0 R e t i n a 1 3 E1 8 ( 1 0 0 ;8AB>2) 5 5=B35=>2A:0O ?;5=:0 D;N>@>3@0D8G5A:0O R e t i n a 7 0 E3 0 , 5 S "@>ABL 8=20;. B5;5A:>?. @B>?548G. 45@52. @C:>OB:>9 A:;04=0O A G5E;>28B0;L 35;L 1 7 5 3 4;O 45B59 8D8:>; ACE>9 D; 5 4>7 !1 0 CB048>= ;LB0@5= 0<? 7 5 <3 3 <; !5 # 5?0:8= 3 0 0 M=B5@8: B01 3 0 0 A?0= 0<? 1 A?0= 0<? 1 <; !5 " 0:@ :>28B ?0AB !3 0 >=>?@8; B01 1 0 28B ?0AB8;:8 !3 0 % @>:B>- 3;825=>; AC?? 4 0 0 <3+ 4 0 < <0;8=0 -=0;0?@8; B01 2 0 <3 !2 0 -A?5@0;L B01 5 0 0 D0@8;L @>@- !>;L 5G51=K5 B@02K 4/ 20== 0 , 5 :3 @>@, !>;L 5G51=K5 B@02K 4/ 20== 0 , 5 :3 G5@540 :>@2 !>;L >@A:85 2>4>@>A;8 4/ 20== 0 , 5 :3 ;0@- !>;L &25B>G=0O A5@8O 4/ 20== 0 , 5 :3 D80;:0 :>@( 535= 0@>4=K9 A ?>4A>;=5G=8:>< 4 0 32 0528I0 ( @A:0O :0?CAB0) 1 0 0 3 :>@>1:0$ @>:;04:8 5;;0 ;0AA8: >20 !1 0 I R "K:25>; :0?A 4 5 0 G:0 D@C:B 3 3 !2 0 ;07 4@0:>=0 >:B>@ ?0AB8;:8 !2 0 0=0=0A >:B>@ ?0AB8;:8 !2 0 0?5;LA8= !B>?BCAA8= B01 !2 0 &5@C:0; 0<? 2 <; !1 0 . 535= CAA:89 ! 4 0 3 00;>:A B01 !2 0 >- H?0 B01 4 0 A>; D;- :0? 1 0 <; Zentiva "5;D0AB B01 1 8 0 "@5=B0; B01 1 0 0 <3 !6 0 . 535= 54>2K9 5 0 3 535= ! N:A 5 0 3@ >EC459 G09 ?0:5BK !3 0 >EC459 G09 ?0:5BK !3 0 @0O ?>IL 10;L70< 4;O @0= 3 5 O@KH=8:0 ?;>4K 1 0 0 3 :>@>1:0) C:C@C7K AB>;18:8 A @K;LF0@>1:0 ">;>:=O=:8 ;8ABLO 5 0 3 :>@>1:0! "KAOG5;8AB=8:0 B@020 3 5 3 :>@>1:0 (0;D5O ;8ABLO 3 5 3 :>@>1:0 0A;> M2:0;8?B>2>5 D; 1 0 20O ?;0ABK@L 7>;L=K9 6 E1 0 A?;0ABK@L ?5@F>2K9 6 E1 0 42>9=>9" !C;LD0F8; N a BN1- :0? 2 0 % 1 , 3 <; !2 <8=078=- . !. 4@065 0 , 1 3 !1 0 8B0<8= :0?A 2 0 0 : C@A:0O 18>D01@8:0
Rhone-Poulenc $C@0F8;8= B01 2 0 <3 !1 0 # 535= 0@>4=K9 28B0<8=878@ 4 0 3 8@0;38= B01 !1 0 ( 8=4 C?) 878= D; 1 5 ; A25G8 !1 0 5B>@>; 0<? !1 0 0 8=B M;0AB8G=K9 8 A< E 1 , 5 9- :;8?A>90 8=B M;0AB8G=K9 8 A< E 3 , 0 9- :;8?A>9 075;8= ; :0?A 1 0 0 <3 !1 0 $0@20F8O
Ankerpharm 8@0 :>@=528I0 1 0 0 3 :>@>1:0 ;5=A;02A:0O $$ <8=078=- . !. 4@065 0 , 0 5 3 !1 0 <8B@8?B8;8= 0<? 1 % 2 70 0<? 4 0 % 1 0 ; ?>@ 1 0 <3 ?0:5B !1 5 -CD8;;8= 0<? 2 , 4 % 5 ;H51=0O ?0;>G:0) !3
5=5AA 5>?>;83;N:8= D; 2 0 0 :>@B87>= 2>:08= D; 0 , 2 5 % 4 0 0 ?;0ABK@L :0BCH:0 5 E5 0 0 ( 8=4 C?) >@=0O :8A;>B0 ?>@ 1 0 3 ;8F8= B01 1 0 0 @>B0B B01 0 , 5 3 !1 0 >?5@0<84 B01 2 <C=8; 0 , 2 5 3 !1 2 Pierre Fabre% #?A028B 8B0<8= ! B01 652 5 0 0 ;45:A- ! ?>@ 5 3 !5 0A;> @5?59=>5 D; 1 0 0 DLO ?G5;8=K9 O4 :@5</ B5;0 7 5 20O B8? @K1:0! 3CB :@>2>>AB0=02;820NI89 -! % >;LF> G=>5 ?5AA0@89 !2 6 !?@8=F>2:0 % - 3 ( A 2 - =5G=, 4=K5 B5E=>;>388 8 <0@:5B8=3 <@ D; 1 0 % 4 0 <; 8@B5: B01 1 0 B5= B01 2 5 <3 !5 6 ( 8=4 C?) :@5= 2 0 ; B01 1 2 5 8 - 4>@>2L5 8:>A8AB :0?A 1 5 0 28=5B B01 !2 1 >- H?0 B01 4 0 70B>@% DB0= 4C D; 0 , 1 % 1 0 <; 3;07=K5 :0?;8 03;ND5@0; 3 B01 !2 0 ( ;0B8D8;;8=0 3/ B0@B@0B 0<? 0 , 2 % 1 <; !1 0 520;38= ( 10@0;38=) B01 !1 0 0 " !0AB D; 5 AB0B8;5=) !C;LD048:A8= B01 0 , 5 3 !1 0 %;>@>D8;;8?B D; 1 % 1 0 0 = AC?? @5:B 2 5 0 D;>:A0F8= D; 2 0 0 <3 1 0 0 ) &8B@0?0@ :0?A !1 0 -@8CA B01 5 :;04:8 5;;0 =>@:;04:8 5;;0 ;0AA8: >20 :;04:8 5;;0 ;0AA8: >20 :>@B A I R !1 0 Mucos Pharma >1M=78 C>28B 4@065 !4 0 , <3;>1C;8= 0=B8AB0D8;>:>::>2K9 1 3 2 !1 0 0;LF89 3 B01 !1 0 0 6520B ;0F84 ! B01 5 0 0 <3 !1 4 ;0F84 ! B01 5 0 0 D 8=B M;0AB8G=K9 1 0 A< E 4 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9. 5=B35=>2A:0O ?;5=:0 R e t i n a 3 0 E4 0 ( 1 0 0 ;8AB>2) 1>A0 ?8D0@< =56=K9 1 0 A0 ?8D0@< A F8:;0< 1 0 A0 ?8D0@< M;8B=K9 1 0 <;
!?5F45B0;L 8=B =/ AB5@8;L=K9 7 E1 4 ( 8=4 C?) 0B0 E8@C@38G5A:0O =/ A 1 0 0 3 30?C@8= 4@065 1 0 0 M ;8=8<5=B 3 0 3 :A8:;02 B01 ?/ > 3 7 5 35=B :@545@< :@5@B82=K9 :@5< 3 5 3 5?0=B5= :@5@CB>= :0?A 3 0 0 :A848= 0<? 1 % 5 <; !1 0 C1=K5 :0?;8 D; 1 0 = 0<? 2 9:0 D; 4 0 <; ( 8=4 C?) 0BEM< $0@@>2>5 D; 3 0 ;810:B5@8= D; 5 4>7 !1 0 ACE>9 0:B>10:B5@8= ACE>9 D; 5 4>7 !1 0 . 52><5B8; <07L ( ,) 3 0 3 BC10 ( 8=4 C?) 0=8=8; B01 5 ;868=0:A :0?A !1 2 >;868=0:A :0?A !6 !5A 0 , 1 % D; 3 35= & !5@=0O ?@>AB0O :A52078= 35;L 2 % 4 0 3 @><35:A8= <8:ABC@0 D; 1 5 0 2>5 D; 4 0 H?8@>= :0?A 1 0 0 H?8@>= :0?A 5 0 <3 !3 0 8;L?@0D5= B01 5 0 0 Yamanouchi/Heinrich Mach 8@>B>= B01 1 0 B>= B01 2 , 5 :A>@C18F8=0 3/ E D; 1 0 28@0:A :@5< 5 % 2 3, <3;>1C;8= 0=B8AB0D8;>:>::>2K9 1 0 0 !1 0 <?@5?0@0B #D0 EB8>; 4 :0@0=40H 3 <; 20<0B5; B01 4 0 , >=865==K45@6. A0E0@0" 0:B>D8;LB@C<8F5B8= D; 1 % 2 5 2>9 @0AB2>@ 8;L30<<0 4@065 1 0 0 H?0= B01 !5 0 9 C@>D5= ACA? D; 1 0 0 <3 5 <; 1 0 0 D5= ( >@B>D5@) <07L 2 % 3 0 3 BC10, 0@0F5B0; ACA?5=78O D; 2 , 4 % 1 0 0 :A8= 0<? 2 % 1 0 <; !1 0 "0@8284 B01 2 0 0 "0CD>= BN1- :0? 4 % 5 <; ( 8=4 C?) ( "8<0;8= D; 1 0 <3 2 @8B5;5 !! B01 5 0 2>9 D/ ? 1 , 5 3 !2 0 5275O :>@5=L 5 0 3 "@5=B0; B01 4 0 0 !1>@ @C4=>9 !4 5 0 3 :>@>1:0 A?0@:03> ;8=8;4@5:A <0:A@8?? !1 0 ;8= >@40D;5:A B01 1 0 20;8A B01 1 5 @18D5@ 4C@C;5A B01 3 2 0 <3 6 0 !B>?BCAA8= :0?;8 D;- :0? 1 0 <; "878= D; 0 , 1 % 1 0 ;8520O :8A;>B0 B01 0 , 0 0 1 3 !5 0 8B@>3;8F5@8= 0<? 0 , 1 % 5 2KE "5E=>;>389 # ;55=:0 ?>4:;04=0O 8 0 A< E 1 . 0 < #D8<A:89 ! 8?5B:0 B@02157>?0A=0O 3;07=0O 5;>A0;8: 0B0 M4C0; 0M@ 2 0 0 4>7 D; 1 0 <;% 8D84C@B5 ACE>9 ?0:5B !3 0 075;8=>2>5 D; 1 0 0 <; "5@2>9 A M D T - 1 4 D "@>ABL 8=20;84=0O B5;5A:>?. <5B0;;. A 70:@C3. ?;0ABOB:>9 !!3 3 ! :0?@>=>20O :- B0 D; 5 % 1 0 0 <; 0;L70< 8BB=5@0 D; 5 0 ; B01 1 5 <3 !3 0 ( 8=4 C?) 8B0<8= 1 2 0<? 2 0 0 <:3 1 = = 1 0 0 0 0 / <; 1 0 <; !1 ;815=:;0<84 B01 5 ;8?@5; B01 2 <3 !3 0 @54C:B0; B01 3 5 <3 !6 0 Servier/Anpharm @5AB0@8C< B01 8 B01 2 0 0 <3 !6 "5BC@0< B01 1 5 0 <3 !5 0 $0@AB02I8:) % -;75?0< ( $5=075?0<) 0<? 0 , 1 % 1 <; !1 0 -=0? B01 1 0 <3/ 2 5 1>O B@020 5 0 3 :>@>1:0 @0?82K ;8ABLO 5 0 3 :>@>1:0 >@>1:0 0:A8:>;4 ?>@ 5 3 !1 0 ;8= 5BC=L ;5C=8407>; D; 5 0 0 <3 1 0 0 =) ;:5< 0DB878= BN1- :0? 0 , 0 5 % 1 5 <;
$0@5:B 5>A<@ 3 3 !3 ( 8=4 C?) 07828= :0?;8 D; 0 , 0 2 5 % 1 0 3;8F5@8= :0?A 1 % 0 , 5 2>:08= 0<? 0 , 5 % 1 0 D5= B01 H8? 2 0 0 28B B01 !3 0 I C N :BO1@L 0@0F5B0; B01 0 , 2 3 !1 0 0B@8O E;>@84 0<? 0 , 9 % 5 A:0- ?CABKH:0 ;0B5:A=0O 2574>G:0 A :>;LF>2K9 2 0 E3 0 0 ;8F5@8= A25G8 2 , 1 1 3 !1 0 84>:08= A?@59 1 0 % 3 8 3 03=8O AC;LD0B ?>@ 2 0 3 $8B>D0@<?0=89) 8<5:A84 D; 1 0 0 <;+ "5@<5B@ 2>< DCB;O@5 "5@?@81>@ Astellas Pharma Europe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y c o m e d / !>B5:A !C<0<54 B01 5 0 0 ?;0ABK@L ?5@F>2K9 6 E1 0 !2 >:B>@ 5@5F 1/ ?5@D. @><35:A8= 8 4@065 8 <3 !2 5 0@=>5 D; 1 0 % 3 0 - "@8:A07>; B01 4 8 0 <3 !1 0 !<5AL 4;O 8=30;OF89 D; 4 0 2538= <07L 5 % 2 0 3 <?8F8;;8=0 B/ 3 B01 0 , 2 5 3 !2 0 D;C18= B01 AC1;8=32 2 5 0 20O ;0AB>G:0 3 3 !2 0 ( N9H0=LF7N) $ 5;GL <548F8=A:0O D; 2 5 0 <8F8= <07L 2 % 1 5 3 <57 :0?A 2 0 <3 !3 0 . ! !B@5?A8;A B01 !2 4 ;- M2:0;8?B $0@4C:B$ "5B@0F8:;8=>20O :A8F8:;8=0 3/ E :0?A 1 0 0 4A:0O C?0:>2:0 Shreya Life Sciences Pvt Ltd ">20@ 0@0F5B0; B01 0 , 5 3 !1 0 !8=0D;0= @C=A:89 7- 4 5=B048= A8@>? 5 0 70 D; 1 0 % 4 0 0 @G8G=8:8 !1 0 >=A:>9 63CG89 &5DB07848< D; 1 3 0;8O ?5@:0@1>:A8;070 3/ E 0<? 5 E5 A @- ;5< !C<0<54 :0?A 2 5 0 <3 !6 . #@0;?;0ABK@L :0BCH:0 1 E3 0 0 ( 8=4 C?) 7>=80784 B01 3 0 0 A25G8 CH=K5 !2 e-mail avikon@avikon-med.ru "5B@0F8:;8=0 3/ E B01 1 0 0 ;5A0= 2 5 35= ( ;;5@35= $# ) >@480<8= 0<? 2 5 % 1 <; !1 0 :20- 0@8A A?@59 D; 3 0 784 B01 5 0 <3/ 2 5 =8AB " " - && @54<5BK 4=>@07>2K9 5 @18=>20O :- B0 A A0E0@>D8B>D0@;:>A5@8; 0<? 2 <; !2 5 $;5:A8= A>;NB01 B01 1 2 5 <3 !2 0 ( -DD5@0;30= # ! A 28B ! B01 H8? !1 0 BC10 -DD5@0;30= # ! A25G8 3 0 0 A5?B B01 1 0 <3 !2 0 ;8= >4- 0:B82 B01 !8 0 0?8;0@ B01 0 , 2 5 3 !1 0 0 :C;8AB !6 0 !1>@ @C4=>9 !1 7 5 3 :>@>1:0 #?A0@8= # ! H8? B01 5 0 0 @F8=0 @0AB2>@ D; 2 5 @>1:0 52>:A ACA? ?0: 1 5 =>=5=4>A:>?>< A:>1>9 !* (?@8F 8=AC;8=>2K9 3 - E :><? 1 D5= B01 2 0 0 <3 !2 0
Worwag Pharma 0?025@8=0 3/ E B01 0 , 0 4 3 !1 0 !B@5?A8;A B01 !2 4 A 28B0=F5=B@0B E2>9=K9 0 , 8 :3 66525;L=8: :>@) !>;L @><0B5@0?8O 4/ 20== 0 , 5 :3 ;8= :>@ !0;8F8;>20O <07L D; 2 % 2 5 3 !:8?840@=0O ?5@84>; 0 , 2 5 % 0<? 2 20O <35:A8= 8 :0?;8 D; 2 0 =E>;8B8= A8@>? D; 1 2 5 20O :>20==0O B8? - 1 ( 1 ;8B@) C7K@L 4/ ;L40 !1 / !0;D5B:0 0=B8A5?B8G5A:0O A D5@0:@8;>20O 1 3 , 5 E1 8 , 5 =B8- - :0?;8 D; 2 5 = 3@0= 1 0 3! 8B0<8= 2 D; 0 , 0 6 2 5 % 1 5 <; $0@= 84@>?5@8B B01 1 , 5 3 !8 ( @0<; B01 5 0 0 $C@>A5<84 B01 4 0 @=528I0 @=8 7 5 3 :>@>1:0( 0;5=4C;0 ( =>3>B:>2) F25B:8 3 0 3 :>@>1:0 ;>M A8@>? A 65;57>< 1 0 0 3 <8=078= 0<? 2 , 5 % 2 ; A25G8 !1 0 A:>@18=>20O :- B0 4@065 !2 0 0 5A0;>; B01 !6 ( 8=4 C?) 8B0<8= 1 0<? 5 % 1 D0@=><0B L D - 2 7 :A8:;02 D>@B5 ?>@ 4/ ACA? 3 1 2 , 5 <3/ 5 <; D; 1 0 0 @18=>20O :- B0 A A0E0@>< ( F8B@CA) B01 !1 0 :@CB:0 - ! 5;;0B0 ( 8=4 C?) $0@0B0 ;8= 8=30;OB>@ 2 0 0 4>7 !1 8=:>@ 35;L 4 0 3 Ipsen Pharma ;8F5@8= D; 2 5 48=>; D; 1 0 0 <; 0@48:5B B01 @5B0@4 4 0 B :0H;O 4/ 27@>A;KE ?0: 1 , 7 3 ACE0O 8;L30<<0 0<? 2 @0B0 D; 2 0 % 3 0 3 >@10:B8= B01 4 0 0 ; 0M@ 1 3 0 3$ 8@078=0<84 B01 5 0 0 @8= D; 0 , 1 % 1 0 5 4@065 5@F 6 9 5 <3 !6 0 "5; B01 !1 0 ?/ > "8@5>:><1 B01 !4 0 $0@<0B5:A :@5< 7 2 3 BC10 $0@@B@0=A ?>@ ?0: !4 %8;0:- D>@B5 D; 3 0
Torrent Labor -=78AB0; B01 !8 0 ?/ >! -B0; B01 0 , 4 3 !1 0 0 ( 8=4 C?) 0:87- D0@EC459 G09 ?0:5BK !3 0 ;8= >EC459 G09 ?0:5BK !3 0 ) >EC459 G09 ?0:5BK !3 0 @B5 B01 0 , 2 5 3 !1 0 0
25,04,2008 !540; ( A540;38=) B01 !1 0 Milve !8=5:>4 A8@>? 1 , 5 <3 2 0 0 <; !;?0458= B01 @0AB2>@8<K5 !1 2 !?0730= 0<? 5 <3 !5 Wockhardt !?07= B01 !2 0 !B@5?B>F84 ?>@ 2 3 "@8E>?>; B01 2 5 0 ;5=78 ( 8=4 C?) %>;>A0A D; 3 0 0 : B01 5 0 30< B01 0 , 2 5 3 !5 0 ( 8=4 C?) 5 535= CAA:89 A :>:>A>:>;04=>9 3;07C@8 4 0 3 8@0 :>@=528I0 5 0 3 :>@>1:0! 0BL- 8- @>1:0 !1>@ @C4=>9 !4 D/ ? 2 , 0 !2 0 * -2:0;8?B0 ?@CB>284=>3> ;8ABLO 5 0 3 :>@>1:0$ 59:>?;0ABK@L 7>;L=K9 ! 6 E1 0
!B8 54!>@1 1=>2;5=85 $ 0=0D0@4# 59:>?;0ABK@L 10:B5@8F84=K9 2 , 5 E7 , 2 0@=8F0 8:0= B01 0 , 0 5 3 !3 0 &8B@0= B01 !1 0 @>?@>B5= 1 0 0 B01 !4 0 Ivax Y a m a n o u c h i / @B0B AWD Novartis Pharm Aventis' 0A:0 B@5EA;>9=0O =0 @578=:0E ( 3>;C10O) :B>2538= B01 ?/ > !1 0 8>B@548= B01 1 0 5 ; B01 1 5 <5B0F8= E8<18=- (?835;L B01 5 2 B01 1 0 <3 !1 0 0 ;0@8B8= B01 1 0 ;4@5:A <0:A@8?? !5 ;8= S.A. Vitoria Laboratorios >?548C< :0?A 2 @8=45= ! =8407>; D; 0 , 5 % 1 0 0 @0; B01 2 0 0 35AB5@>= 0<? 2 , 5 % 1 <; !1 0 C;L<5:A 1M18 <07L 2 0 3 5;8D A25G8 !1 2 !8@40;C4 B01 2 = B01 2 5 <3 !5 0 . " "0:B828= 0<? 0 , 0 1 % 1 0 0 <:3 1 <; !5 "@830=- 0<? 2 3@0D8= 0<? 6 0 % 2 0 <; !1 0 Innothera Lab. $0@<0B5:A B01 203 2 0 : B01 2 5 <3 !6 0 -4=8B B01 1 0 EC459 G09 ?0:5BK !3 0 :;C1=8:03 !:>@0O ?>IL :@5<- 35;L 7 5 B A8=O:>2 8 CH81>2) 25@>1>O B@020 D/ ? 1 , 5 3 !2 0 " OBK ?5@5G=>9 ;8ABLO D/ ? 1 , 5 3 !2 0 " "KAOG5;8AB=8:0 B@020 D/ ? 1 , 5 3 !2 0 # #:@>?0 ?0ECG53> ?;>4K 1 0 0 3 :>@>1:0 '01@5F0 B@020 5 0 3 :>@>1:0$ 0A;> M2:0;8?B>2>5 D; 1 5 <; ( 8=4 C?) ( 0:F8=0 BC;O@5<89=0O 6820O 07 >=>@<8; B01 1 5 <3 !3 0 8AB0B8= A25G8 203 5 0 0 0 0 0 !1 0 $8;LB@C2=8:0 ?;>4K D/ ? !2 0 / -@2K (5@AB8AB>9 ( >;- 0;0 ) B@020 3 5 3 :>@>1:0 9:0 D; 2 5 ;0 =8:>B8=0B 0<? 2 G:8 S o f t C a r e !4 5 A >3@0=8G8B5;5< 4 0 1 5 ! 0@;O 20==0O 1 0 < :@845@< :@5< 0 , 0 6 4 % 1 5 3 BC10 ;<035;L D; 1 7 0 ; AC?? @5:B !1 0 8A0:>48; AC?? @5:B 1 0 <3 !1 0 075;8= ;8= D; 0 , 1 % 1 0 70 - D; 5 % 2 0 0 =04>B@>?8= E>@8>=8G5A:89 0<? 1 0 0 0 !5 86D0@:;>?@0<84 0<? 5 <3/ <; 2 <; !1 0 097 B01 5 0 3;8F5@8= B01 0 , 5 BB0 :0?;8 D; 5 0 ; A?@59 5 8 3- @>:A8:A8@ 4;O ?@83 @- @0 7 5 0 @B0= - D; 6 % 5 0 0 :A8= B01 2 0 0 D@045:A D; 5 D0=B8= 0<? 0 , 0 2 5 % 1 <; !1 0 1 "5B@0F8:;8= + =8AB0B8= B01 1 0 0 0 0 0 !1 0 ( 8=4 C?) &8D@0= B01 5 0 0 <3 !1 0 -:A8?8= D; 1 % 5 <; -=0< B01 1 0 <3 !2 0 < * 5AA3> F25B:8 3 5 3 :>@>1:0 @CH8=K :>@0 5 0 3 :>@>1:0 4C20=G8:0 :>@=8 1 0 0 3 :>@>1:0 !1>@ 65;C4>G=K9 !3 5 0 3 :>@>1:0 '01@5F0 B@020 3 5 3 :>@>1:0 >40 4;O 8=J5:F89 0<? 5 ?5@84>; 0<? 0 , 5 % 1 9 E8<88 828G0 &5D07>;8= N a D; 1 3 2/ 2 2/ ;8= 4@065 0 , 1 3 !1 0 :B>2538= B01 ?/ > !5 0 . 59:>?;0ABK@L 7>;L=K9 ! 2 * 5 2 :>A:0- ?CABKH:0 ;0B5:A=0O 01>G:0) !>A:0- ?CABKH:0 ;0B5:A=0O 01>G:0 ( 8=4 C?) 5 !>A:0- ?CABKH:0 ;0B5:A=0O 2574>G:0 A :>;LF>A:0- ?CABKH:0 ;0B5:A=0O !>;=KH:> ( 8=4 C?) 4 !>A:0- ?CABKH:0 ;0B5:A=0O !B@5:>70 A :>;LF>< ( 8=4 C?) " - 8@- $0@:A8= 0<? 2 % 5 <; !1 0 815:A8= B01 1 0 0 <3 !2 0 84070 6 4 0?@8; ( -=0;0?@8;) B01 1 0 ?84 B01 1 <8F8= 3/ E 0<? 3 0 % 1 <; !1 0 578@B5 B01 1 4 0 <3 !8 0 8@0<8AB8= D; 0 , 0 1 % 5 0 8= 3@0= 1 0 3 ( :>@) >B8;8C< B01 1 0 9 =0AB>9:0 D; 2 5 AC;LD0B 0<? 3 0 % 1 0 @84 D; 0 , 9 % 2 5 0 Lannacher Heilmittel 5>- =C7>; A25G8 !1 0 8:>@5BB5 1 0 @5BB5 5 20O H- 1@0 ( =>- H?0) 0<? 2 - H?0 B01 4 0 D5= $>@B5 4 0 0 D5= B01 2 0 0 D5= B01 2 0 0 <3 !6 :A0:A0D5= :A0F8= ! B01 2 0 0 5:>D0@ 0=0=38= 0<? 1 0 <; !5 & 548:C;8F84=K9 H02A:0O $$ 5@BCAA8= D; 1 0 0 <; ( 1 2 5 3) 8<0DCF8= B01 1 0 0 <3 !2 0 <?@5?0@0B " 8?>;LD5= 4@065 2 5 <3 !2 0 8@0=B5; ACA?5=78O D; 1 0 <; Marvel Life Sciences! 8@0F5B0< B01 2 0 0 43C7=8:8 4;O 27@>A;KE S u p e r S e n i a i r m e d i u m 3 0 HB !525@=0O 725740 " 3 !51>7>; ( :5B>:>=07>; 1 % ) H0B ?5@E>B8 5 38; 5 <3 1 <; D; 1 0 0 <; B@828= A?@59 0 , 1 % 1 0 <;" !8=0D;0= ;8=835AB5@>= 0<? 1 % 1 B :0H;O !2 4 D>;L38@. AB@8?K 59:>?;0ABK@L S t r i p 4 , 0 E 1 0 , 0 078;8? B01 2 0 :0@1>=0B ?>@ 1 0 3 -=0< B01 2 0 =F5=B@0B E2>9=K9 0 , 8 :3 :54@ :>@ 807>;8= B01 0 , 1 3 !1 0 ;59 $- 6 1 5 3 BC10# >@3;8:0@4 ( :>@3;8:>=) 0<? 1 :8=070 7 5 0 0 0 0 4/ 8= 4>=8A- @> ( 8=4 C?) ; A8@>? 1 0 0 3 5=B5@ B01 5 0 0 <3 !1 0 0 K R K A / :@8E8= 5457 ( @0A35457) D; 4 0 0 DC;L28= B01 0 , 1 2 5 3 !2 0 8=5:A :0?A !1 6 $ 8;>:0@?8=0 3/ E BN1- :0? 1 % 1 , 3 :0@?8=0 3/ E D; 1 % 5 <; !5 A 7>9 $8=;5?A8= @5B0@4 B01 2 0 0 @>?8@0<8= ( !C?@0AB8=) 0<? 2 0 <3/ <; 1 <; !5 Ebewe -DD5@0;30= # ! A25G8 1 5 0 G09 &5;51=0O ?>;O=0 !9 D/ ? 2 3 !2 0 >G53>==K9 @18=>20O :- B0 0<? 5 % 1 <; !1 0 A?0@:0< B01 !1 0 8B0D5=0: <07L 1 % 3 0 3 < 53@CAB8= :0?A 4 2 5 <3 !3 0 $0@;5B5 ?0AB8;:8 !3 0 1/ A0E0@0 !@B5 B01 !1 0 0 %>=4@>:A84 =F5=B@0B E2>9=K9 0 , 8 :3 ?8EB0 :>@( !>;L @><0B5@0?8O 4/ 20== 0 , 5 :3 @ "K:25>; :0?A 4 5 0 ;L @><0B5@0?8O 4/ 20== 0 , 5 :3 15@30B :>@ 535= CAA:89 2K9 4 0 3 >70 $ F5A>;L D; 2 0 0 D0@?;0ABK@L 10:B5@8F84=K9 3 , 8 E3 , 8 C7K@L 4/ ;L40 !3 @184>; B01 5 0 20O B8? - 1 ( 1 ;8B@) #A?>:>9 B01 !2 0 $5=075?0< B01 1 <3 !2 0 $5=075?0< B01 1 D0@;O@8A 4 59:>?;0ABK@L 10:B5@8F. =01>@ 5A5;K5 4@0:>=G8:8 !1 2 !818@A:>5 74>@>2L5 &
@>35= ( <?@5?0@0B) A:>D5= B01 !1 0 A:>@CB8= B01 !5 0 078;8? B01 2 0 -CD8;;8= 0<? 2 , 4 % 1 0 <; !1 0 Alembic !8=B57
" "@594 Pfizer Sopharma Beaufour-Ipsen "5@2>9 A M D T - 1 3 # N3>;O @0AB2>@ A 3;8F5@8=>< D; 2 5 3 0;L70;>B0O 725740 4 3 0=0D0 35:A0; A8@>? D; 1 0 0 40@A:0O $$# 8H=52A:>3> ;8=8<5=B 1 0 0 3 ( 8=4 C?) 545;8:A :0?;8 D; 5 0 @0; 0M@ D; 0 , 2 % 4 0 <; D;C18= :0?;8 D; 2 0 <; 5@BCAA8= D; 1 0 0 <040 :> 3 , 5 3 $8B>A25G8 CH=K5 !2 45BA:85 $8B>A25G8 CH=K5 !4 45BA:85 8:@>35= ( ) 8F8;;8= 5 D; 1 5 0 0 BKA @C4=>9 M;8:A8@ D; 2 5 A:0- ?CABKH:0 ;0B5:A=0O 01>G:0 A :>;LF>B8:81 59:>?;0ABK@L ?5@F>2K9 1 0 E1 8 >:B>@ 5@5F 1/ ?5@D. CB048>= B01 0 , 1 5 3 !1 0 8B0<8= 6 0<? 5 % 1 :A8= 0<? 0 , 0 2 5 % 1 ?@8; B01 2 5 <3 !2 0 ;8<0:A0= B01 !2 0 5@BCAA8= D; 1 0 0 <; -=0;0?@8; B01 5 %8@> ;NA :@5A>;L D; 4 0 0 <; 078;8? B01 1 0 <3 !2 8 5:A0= 0<? 4 <3 2 @ #A?>:>8B5;L=K9 !3 D/ ? 2 3 !2 0 59:>?;0ABK@L 10:B5@8F84=K9 6 E1 0 $5=075?0< B01 0 , 5 A>;L D; 2 0 0 <; <<C=0; D; 5 0 <; 0= 0M@ D; 4 5 3 >;4@5:A E>B@5< ?0: !5 ;8= >;4@5:A E>B@5< ?0: !5 <54- ;8= >@480<8= D; 1 5 20O 38; 5=B0 35;L 2 0 3 BC10 C:0;B8= B01 !1 0 Novartis Enterprises PVT. LTD -@8B@>@0- $0@;5B B01 2 5 0 45;0: B01 !1 0 ( 8=4 C?) :@8E8= Ranbaxy Polfa Jelfa S.A.
Dr.Reddy's
Berlin-Chemie& 0B0 38385=8G5A:0O D0A>20==0O ?> 5 0 3 5;;0AB578= B01 !1 0 # 8=?>F5B8= B01 0 , 0 0 5 3 !5 0 ( 8=4 C?) " 5B8;C@0F8; B01 0 , 5 3 !5 0 ( 8=4 C?) 8> =- ! 0<? 5 @ !1 0 @0AB2>@8<K9 $5=N;LA :0?A !1 0 "5@0D;5:A :0?A !6 0 $5=075?0< 0<? 0 , 1 % 1 <; !1 0 -AA5=F80;5 0<? 5 <; !5 0@;O 20==0O 2 =04>B@>?8= E>@8>=8G5A:89 0<? 5 0 0 !5 A @0AB- ;52>:08= 0<? 2 % 2 ;>; B01 1 0 0 4:;04=>9 !3 6 !?@8=F>2:0 % - 8 ( A 2 - =5G=, 2:0 % - 1 5 !C4=> ?>4:;04=>5 @578= !2 !C4=> ?>4:;04=>5 @578= !3 :A8:;02 ?>@ 4/ 8= D; 1 , 2 3 !5 @8D>= B01 2 , 5 ! A?8@8= :0@48> B01 3 0 0 B5=>;>; B01 5 0 B5: 0M@ 1 0 0 7. 830=B>; D;- :0? 1 0 <; = 1 A25G8 1 5 0 BKA !1 0 8D5@>= 2 A25G8 5 0 0 BKA !1 0 8D5@>= 3 A25G8 1 :A848= 0<? 0 , 5 % 1 0 <; !1 0 8D5=8= B01 1 0 0 B025@8=0 3/ E B01 4 0 <3 !5 0 1C:;8= B01 4 0 0 @>;0: 0<? 3 0 <3/ <; 1 0:A8; B01 1 2 , 5 - 52><8F5B8= BN1- :0? 0 , 2 5 % 1 0 ; 0<? 5 % 2 @0B>@8A @5AB0@8C< B01 4 <3 !3 0 S e r v i e r / 0:87- D0@A5?B B01 1 0 <3 !1 0 ;8= $5=8AB8; 5=F828@ 1 % :@5< 2 3 $;0D;>:A0F8= B01 5 0 0 <3 !1 0 -:78D8= ( ;0<878;) :@5< 1 % 1 0 3 -:78D8= B01 2 5 0 O@KH=8:0 ?;>4K 1 0 0 3 $8B>- >B >2=8:0 ?;>4K 1 0 0 3- >A:8B>; 0M@>7>;L C=825@A0;L=0O 70I8B0 1 5 0 A:8B>; 684:>ABL >B :>2 =0 4 5 =>G59 8>30@46 >A:8B>; 684:>ABL >B :>2 =0 4 5 =>G59 56=0O 70I8B0( >A:8B>; 684:>ABL >B :>2 =0 6 0 =>G59( >A:8B>; 684:>ABL >B :>2 =0 9 0 =>G59* >A:8B>; :0@0=40H >B :>2 3 0 3 27@>A;K9' >A:8B>; :>@ + 1 0 ?;0AB8=) 1 >A:8B>; :>@ + 684:>ABL =0 4 5 =>G59) ) >A:8B>; :@5< 8=B5=A82=0O 70I8B0 D; 5 0 A:8B>; ;5=B0 ;8?:0O >B A:8B>; ;5=B0 ;8?:0O >B A:8B>; ;>AL>= >B :>2 D; 1 0 0 A:8B>; ?;0AB8=K >B :>2 !1 0 9 >A:8B>; A?@59 56=0O 70I8B0 >B :>2 D; 1 0 0 A:8B>; A?@59 >B :>2 D; 1 0 0 :B>@ ?;0ABK@L :0BCH:0 2 E5 0 0 ( 8=4 C?) F 8=B M;0AB8G=K9 1 0 A< E 1 , 0 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9+ >@F0 ?B8GL53> ( !?>@KH0) B@020 5 0 3 :>@>1:0! 0BL- 8- @>1:0 ;N:>70 0<? 4 0 % 5 @B5 :0?A 3 0 0 18;L=0O ?5@2>9 ?>I8
8B0;D0@20==0O ?> 2 5 0 3+ 01>@ 38=5:>;>38G5A:89 $ ( >4=>@07>2K9) 80;>= !525@=0O 8B09A:0O $ B4 =C7>; A25G8 @5:B !1 0 "$ 0<? 1 % 1 D03 AB0D8;>:>::>2K9 D; 2 0 @D0=>;0 B0@B@0B H?@8F- BN1 0 , 2 % 1 <; !5 8B0<8= :0?A 3 3 0 0 5 0 B80784 B01 1 0 0 7< 0 D; 1 0 % 2 0 0 AB8@ %$ ! 83>:A8= B01 0 , 2 5 D5=0: 35;L 1 % 3 0 3 Wave Pharmaceuticals >:B>@ A8@>? D; 1 0 0 ;4@5:A E>B@5< ?0: !5 0 A@>48=0 A5=8:0; :0?A 1 2 0 = 0<? 1 % 1 =8407>; B01 0 , 2 5 3 !1 0 5B@>=8407>; B01 0 , 2 5 3 !2 0 8AB0B8= A25G8 203 2 5 0 0 0 0 !1 0 &5=0 U S D - 5 2 B01 !1 0 0 Sanofi-Synthela" 8B@>:A>;8= B01 5 0 D5= #;LB@00? :0?A 2 0 0 <3 !1 0 8@0=B5; ACA?5=78O D; 1 5 <; 0DB878= BN1- :0? 0 , 1 % 1 5 F84 ;8=8<5=B 5 % 3 0 3 BC10* ;8F8= B01 1 0 0 4JO7KG=K5 818:>@ 0 , 2 5 4:;04=>9 !1 IND Diagnostic Inc "5AB =0 15@5ABL K N O W N O W " 40@>= ( :>@40@>=) B01 0 , 2 3 !3 0 ! =0?@8;8= B01 4 0 <3 !1 0 0 ( 8=4 C?) 4 535= CAA:89 A 87N:>;04=>9 3;07C@8 4 0 3( 03C;L=8:0 1>;>B=>3> ?>1538 5 0 3 :>@>1:0! OBK ?5@5G=>9 ;8ABLO 5 0 3 :>@>1:0 >@>1:0 8D84C7 !3 0 803@0 B01 5 0 <3 !4 . 8B0<8= D; 3 , 4 4 % 1 0 ;8A8=B57 ( 0;5=4C;0 ( =>3>B:>2) F25B:8 5 0 3 :>@>1:0. !>;L >@A:85 2>4>@>A;8 4/ 20== 0 , 5 :3 DC:CA :>@ 535= 0@>4=K9 H:>;L=K9 4 0 3 >G:8 15@57K 5 0 3 5@8<0:A -=5@468 B01 !1 0 8B8;8= 0<? 2 % 5 ;>4:>2>3> :>@=O A8@>? D; 1 0 0 =><5B@ <548F8=A:89 45;L !B0=40@B - L2>2480;5:# 5:A0= ACA? D;- :0? 0 , 1 % 5 ;L D; 2 0 0 ;L D; 4 0 0 ;>= B01 5 @=>9 :- BK A?8@B>2>9 @- @ D; 3 % 2 5 D5=0: B01 5 0 # 59:>?;0ABK@L 10:B5@8F84=K9 2 , 3 E7 , 2 >O@KH=8:0 =0AB>9:0 D; 1 0 0 ? D; 6 0 45;0: $8B> A8@>? D; 1 0 0 3 5=B>28B B01 !5 0 ?/ >! "8;>; 0 , 2 5 % 1 0 <; !1 :@KH:0- :0? "8;>; 0 , 5 % 1 0 <; !1 :@KH:0- :0? -:A8?8= 0;M=4 3 0 3 45BA:0O D;0:>=- A?@59 -::>;5=4 @8AK?:0 -::>;M=4 4 0 3 45BA:0OE 8=B M;0AB8G=K9 7 , 5 A< E 2 :>9 @0ABO68AB8 A 70AB56:>9- :;8?A>9 '5@=8:0- D>@B5 B01 0 , 2 5 3 !5 0 0A;> ?8EB>2>5 D; 2 5 <; ( 8=4 C?) !8=0< @0=40:A8= B01 5 0 <3 !2 0 8D;N:0= :0?A 1 5 0 :B>@ ?0AB8;:8 !2 0 :;C1=8:0 >;>15=5 35;L 5 0 3 BC10
Mercklle GmbH >@5:A 2 5 0 <3+ 1 0 B5= B01 2 5 :08= 3/ E 0<? 2 % 2 <; !1 0 0:A830= B01 5 0 0 7 1 0 3 !1 10;;>= 8D548?8= 4@065 1 0 <3 !5 0 5;F5@ ACA? D; 1 8 0 :>9 3@0= 1 0 3 $>@;0:A ?>@ ?0: 1 0 3 !2 0 &5@51@>;878= 0<? 1 ;878= 0<? 5 : B01 1 0 0 : B01 1 0 0 @0 1 0 0 3 :>@>1:0 >?CE0 :>@5=L 5 0 3& 0B0 38385=8G5A:0O D0A>20==0O ?> 1 0 0 3 :B>2538= :@5< 5 % 2 0 3 5=0;38= B01 !2 0 5@8<0:A @5<8C; B01 !5 6 >;8F8= B01 4 0 0 <3 !2 0 5;8D ?BCAA8=- D8B> A8@>? D; 1 0 0 <; A D0=B8= 0<? 0 , 0 2 5 % 1 <; !1 0 & !C:@078B ( 70= BN1- :0? 4 % 1 0 <; ( 8=4 C?) "5@0D;5:A :0?A !3 0 $ =40?0=0; :@5< 5 % 3 0 3 ;8= B01 !6 0 >=B@0:BC15:A 35;L 2 0 3 !1 BC10 Merz >:>84 20O =0 =0AB>9:0 D; 2 5 ;870B 0<? 1 <; !1 0 -=0? B01 5 <3 !2 0 C1=0O ?0AB0 0:0;NB 0:B82 5 0 <; C1=0O ?0AB0 0:0;NB C09B 5 0 D>@<C;0 5 0 @ 5 0 ?;0ABK@L :0BCH:0 4 E2 5 0 ( 8=4 C?) <8:A8= B01 1 2 5 O@KH=8:0 =0AB>9:0 D; 2 5 @0 02:070 5:A8:>= A25G8 !1 0 CBB0;0:A :0?;8 D; 3 0 <; 8D5=8= B01 1 0 0 ?5@84>; 0 , 2 5 % 0<? 5 4><0@8= 2 0 0 B01 2 0 0 <:3 !5 0 0@=K9 A?8@B D; 1 0 % 4 0 ;4@5:A B01 !1 2 >=48;8= D; 0 , 5 % 3 , 5 ?@8; ( -=0;0?@8;) B01 2 0 >1;5?8E>2>5 D; 5 0 <; ( D0@?59=>5, 8=4 C?, A>45@60=85 :0@>B8=>84>2> = 1 3 0 7>;L D; 0 , 0 5 % 1 0 :0@?8=0 3/ E D; 1 % 5 ;4 B01 !1 0 "015:A B01 !1 0 0 "5920 ?0AB0 5 0 3 BC10 $C@038= B01 5 0 @35:A848= 183;N:>=0B D; 0 , 0 5 % 1 0 0 <; ( A?@59) =B8; ACA?5=78O D; 1 2 5 A35;L 35;L 2 2 5 3 ( 8=4 C?) !8;A35;L ?0AB0 2 2 5 3 ( 8=4 C?) -DD5@0;30= # ! A25G8 8 0 B5; 3 , 6 B5; :B82 A F8=:>< 1 , 2 G=K5 1 0 D@0 A?@59 D; 1 5 A0 8=:0A A8@>? D; 9 0 <;?>;8A0 =0AB>9:0 D; 2 5 D;C8<CF8; 0M@ 1 0 <; D; Zambon Group $0ABC=4@>;>= 0<? 0 , 1 @5=L 7 5 3@ ?0:. ! "KAOG5;8AB=8:0 B@020 5 0 3 :>@>1:0# &5DB@80:A>= D; 1 3 2/ 2 2/ < ( 8=4 C?) 0;L70< 8:C;O 7 5 DLO ?G5;8=K9 O4 :@5</ B5;0 1 2 5 DLO M:AB@0:B ?8O2:8 :@53 1 2 5 @0 5 0 3 :>@>1:0/ %;>@35:A848= 183;N:>=0B D; 0 , 0 5 % 1 0 0 ?;0ABK@L :0BCH:0 1 E5 0 0 ( 8=4 C?) @CH8=K :>@0 D/ ? 2 3 ! 2 0 >2>:08= D; 0 , 2 5 % 2 0 0 E>; B01 2 1 0 <3 !2 4 5@8=0B D;- :0? 0 , 2 5 % 1 0 ; B01 1 2 0 = 45BA:89 B01 !2 0 @B@>D>>= B01; !4 0 8:;>D5=0: 0<? 7 5 <3 3 <; !5 7 "5@<5B@ 2>@ >4=>@07. AB5@8;L=K9 ( F5=B@0;L=>5 :>?L5) ! 5=78;15=7>0B0 = D>@B5 B01 1 0 <3 !3 0 ) 8@0<8AB8= D; 0 , 0 1 % 1 5 0 <; A @0A?K;8B5;5 $8B> 548F8=0 % 5@0?0<8;0 3/ E B01 4 0 <3 !5 0 ( 8=4 C?) =0;L38= AC?? 1 0 0 <3 !1 0 4/ 45B59 !C?@8=E> A8@>? D; 1 0 0 G:0- 15@5B (0@;>BB0 ( 3>;C10O) :A8F8;;8= B01 0 , 2 5 3 !2 0 ;N:>70 D; 5 % 4 0 0 <; 8D;N:0= :0?A 5 0 =B@0F5?B8=- " A25G8 !1 0 >@8=45= ;8= <8F8=0 AC;LD0B D; 1 3 !1 "02538; 0<? 0 , 1 % 2 A?@59 0 , 0 5 % 1 0 <; &8==0@878= B01 2 5 AB>? D; 0 , 0 5 % 1 0 2538= B01 ?/ > !3 0 F8:;>28@ B01 2 0 0 <3 !2 0 # 5=B0<8F8=0 AC;LD0B 0<? 4 % 2 ;L D; 4 5 0 A:0- ?CABKH:0 ;0B5:A=0O #;K1:0 A :>;LF><! :2045B@8< 28B0<8= D 3 D; 1 0 ?C@8=>;- -38A B01 3 0 0 ? 0<? 1 0 <3 1 <; !1 0 Biotehnos S.A.( ;L1C<8= D; 1 0 % 1 0 0 B5:A @><35:A8= 4 D; 6 0 <; =0 3;07=K5/ CH=K5 :0?;8 D; 5 <; 80=5- 3 5 4@065 !2 1 0<878; :@5B8=>20O :- B0 B01 5 0 @20A: B01 1 0 <3 !1 4 . @C=30; :0?A 1 0 0 <3 !1 4 # 5==8 =0?0:A 4@065 2 5 @;
-
inerta
datamax
outlook
-
macintosh
stihl
russia music awards
-95
-
summer
88
32
-
xxx
sharp ar-5415
pki
zip lock
certification microsoft
8800 gold
264-27-00
8800 gold edition
kyiv apartments service